BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5172361)

  • 1. [Activity of B663 in lepromatous leprosy. Therapeutic trial].
    Pene P; Carrie J; Bourgeade A; Bolliot Y
    Bull Soc Pathol Exot Filiales; 1971; 64(4):407-15. PubMed ID: 5172361
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapeutic trials in leprosy. 3. Pilot trial of a riminophenazine derivative. B.663, in the treatment of lepromatous leprosy.
    Pettit JH; Rees RJ; Ridley DS
    Int J Lepr Other Mycobact Dis; 1967; 35(1):25-33. PubMed ID: 5336368
    [No Abstract]   [Full Text] [Related]  

  • 3. Histochemistry of B663 pigmentation: ceroid-like pigmentation in macrophages.
    Sakurai I; Skinsnes OK
    Int J Lepr Other Mycobact Dis; 1977; 45(4):343-54. PubMed ID: 75860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B.663 (Geigy 30. 320) in the treatment of leprosy. A preliminary report.
    Devadason C
    Acta Trop; 1969; 26(3):265-9. PubMed ID: 4391239
    [No Abstract]   [Full Text] [Related]  

  • 5. [Action of B663 on obstinate reactogenic forms of Hansen's disease].
    Rostant MM
    Bord Med; 1970 Apr; 3(4):1033-4 passim. PubMed ID: 5422391
    [No Abstract]   [Full Text] [Related]  

  • 6. Double-blind controlled clinical trial of clofazimine in reactive phases of lepromatous leprosy.
    Karat AB; Jeevaratnam A; Karat S; Rao PS
    Br Med J; 1970 Jan; 1(5690):198-200. PubMed ID: 4904935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial effects of G 30'320 Geigy (B663) in lepromatous leprosy.
    Hastings RC; Trautman JR; Mansfield RE
    Dermatol Int; 1969; 8(1):21-7. PubMed ID: 5343403
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of leprosy with Lampren (B.663 Geigy).
    De las Aguas JT
    Int J Lepr Other Mycobact Dis; 1971; 39(2):493-503. PubMed ID: 4948089
    [No Abstract]   [Full Text] [Related]  

  • 9. A study of skin pigmentation by clofazimine.
    Levy L; Randall HP
    Int J Lepr Other Mycobact Dis; 1970; 38(4):404-16. PubMed ID: 5534493
    [No Abstract]   [Full Text] [Related]  

  • 10. B 663 (Lampren) in mycobacterial infections.
    Pettit JH
    Br J Dermatol; 1969 Oct; 81(10):794-5. PubMed ID: 5379868
    [No Abstract]   [Full Text] [Related]  

  • 11. Clofazimine (B663, Geigy) in leprosy reactions.
    Smith RB
    Australas J Dermatol; 1972 Apr; 13(1):31-5. PubMed ID: 5082494
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of the administration of B663 [G 30 320, Lamprene, clofazimine (Geigy)] on three groups of lepromatous and borderline of leprosy.
    Rodriguez JN; Abalos RM; Reich CV; Tolentino JG
    Int J Lepr Other Mycobact Dis; 1974; 42(3):276-88. PubMed ID: 4617715
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of B.1912, a new riminophenazine derivative in murine leprosy.
    Chang YT
    Int J Lepr Other Mycobact Dis; 1970; 38(4):417-21. PubMed ID: 5534494
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemotherapeutic trials in leprosy. 5. A study of methods used in clinical trials in lepromatous leprosy.
    Waters MF; Rees RJ; Sutherland I
    Int J Lepr Other Mycobact Dis; 1967; 35(3):311-35. PubMed ID: 4917107
    [No Abstract]   [Full Text] [Related]  

  • 15. Controlled drug trial of B.663 compared with DDS. Preliminary (48 week) report.
    Tolentino JG; Rodriquez JN; Abalos RM
    Int J Lepr Other Mycobact Dis; 1971; 39(3):738-41. PubMed ID: 5169924
    [No Abstract]   [Full Text] [Related]  

  • 16. Lamprene: first results of treatment in the Netherlands in a group of 6 leprosy patients.
    Hogerzeil LM
    Dermatologica; 1971; 143(6):339-44. PubMed ID: 5150817
    [No Abstract]   [Full Text] [Related]  

  • 17. A treatment of corticosteroid-dependent lepromatous patients in persistent erythema nodosum leprosum. A clinical evaluation of G.30320 (B663).
    Imkamp FM
    Lepr Rev; 1968 Jul; 39(3):119-25. PubMed ID: 4298736
    [No Abstract]   [Full Text] [Related]  

  • 18. Lipids in leprosy. 2. Histochemistry of lipids in human leprosy.
    Sakurai I; Skinsnes OK
    Int J Lepr Other Mycobact Dis; 1970; 38(4):389-403. PubMed ID: 4102020
    [No Abstract]   [Full Text] [Related]  

  • 19. The antileprotic action of clofazimine (B663, G30, 320, Lamprene).
    Azulay RD; da Silva NC; Zeo A; Portela AB; Franca JC; Peluso LL
    Int J Lepr Other Mycobact Dis; 1974; 42(1):13-8. PubMed ID: 4607163
    [No Abstract]   [Full Text] [Related]  

  • 20. [Trial of a new leprostatics (B-663) in the treatment of lepromatous leprosy].
    Renders A
    Ann Soc Belges Med Trop Parasitol Mycol; 1968; 48(6):625-35. PubMed ID: 5759964
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.